Kaiser Foundation Health Plan Northern California
diltiazem HCl (diltiazem HCl)
Drugs for the Heart : Drugs for Abnormal Heart Rhythms
  • Ovarian Cancer:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified
    Drug Policy Based On: FDA Approved Indications
    Diagnosis Types: 3 of epithelial ovarian, fallopian tube, or primary peritoneal cancer;maintenance treatment after a complete or partial response to platinum-based chemotherapy;Recurrent disease

<< Return | Back to top